canal wall down tympanomastoidectomy. Chronic tubotympanic suppurative otitis media,Chronic atticoantral suppurative otitis media,Other chronic suppurative otitis media,Suppurative otitis media, unspecified
Conditions
Interventions
Intervention 1: use of Gelfoam in control group. Intervention 2: use of Hyaluronic Acid in intervention group.
Treatment - Surgery
use of Gelfoam in control group
use of Hyaluronic Acid in intervention group
Sponsors
Vice Chancellor of Research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) patients more than 18 years old; 2) tympanic perforation =50 %. Exclusion criteria: 1) pre operative medical problems such as asthma, diabetes, coagulation disorders, cardiovascular disease, basic metabolic disorder, immune system deficiency and chronic liver or renal disease; 2) Smoker patients; 3) revision canal wall down tympanomastoidectomy; 4) Patients with preoperative mixed hearing loss; 5) Patients with contra-lateral ear disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tympanic membrane graft success rate. Timepoint: 6 months after operation. Method of measurement: Observation by ENT specialist.;Hearing results. Timepoint: before operation - 6 months after operation. Method of measurement: pure tone audiometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSareh Roosta
Center for Development of Clinical Studies, Vice Chancellor of Research and Technology, Shiraz Unive
Outcome results
None listed